(1)
Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases As Potential EGFR Inhibitors for NSCLC. AJPS 2026, 25 (5), 973-991. https://doi.org/10.32947/ajps.v25i5.1318.